Clinical trial: Prenatal DHA prevents blood-pressure increase from obesity during childhood

4 min read /
General Nutrition Public health
Clinical trial: Prenatal DHA prevents blood-pressure increase from obesity during childhood

Research published today in JAMA Network Open by investigators at the University of Kansas and KU Medical Center finds pregnant mothers who daily consumed 600 milligrams of docosahexaenoic acid (DHA) -- an omega-3 fatty acid found in prenatal vitamins, fish-oil supplements and fish meat -- protected their offspring from the blood pressure-elevating effects of excessive weight in early childhood.

Save (for later)

Reference

Kerling EH, Hilton JM, Thodosoff JM, Wick J, Colombo J, Carlson SE. Effect of Prenatal Docosahexaenoic Acid Supplementation on Blood Pressure in Children With Overweight Condition or Obesity: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2019;2(2):e190088 - Link

Links: https://www.eurekalert.org/pub_releases/2019-02/uok-ctp021919.php

lock

This content is for registered users only.
Registration is free and reserved for healthcare professionals.